Scientific article| Volume 37, ISSUE 7, P1307-1312, July 2012

Steroid Injection and Needle Aponeurotomy for Dupuytren Contracture: A Randomized, Controlled Study


      To compare flexion deformity at 6 months in patients with Dupuytren contracture who had percutaneous needle aponeurotomy (PNA) combined with a series of triamcinolone acetonide (TA) injections to that of patients who had PNA alone.


      Forty-seven patients with Dupuytren disease who were candidates for PNA (at least 1 contracture of at least 20°) participated in the study. Patients were randomized either to receive TA injections immediately following and 6 weeks and 3 months after the procedure or to receive no injections. Injections were administered into cords. The number of injections and the amount of TA per injection was determined based on the number of digits involved and the cord size. All subjects returned for 3 follow-up visits after the procedure, and contractures were measured using a goniometer. Change in total active extension deficit (TAED) was analyzed using a repeated measures analysis of variance to assess for differences between groups, time points, and interaction between group and time point. Descriptive statistics were calculated for all variables of interest. Continuous measures were summarized using means and standard deviations.


      There was no significant difference in TAED between groups before cord aponeurotomy. Correction at 6 months was 87% of preoperative TAED for the TA group versus 64% for the control group. This difference was statistically significant. The amount of TA administered did not correlate with TAED improvement.


      The study group who received TA in combination with PNA experienced a significantly greater degree of correction of flexion deformity at 6 months than those who had PNA alone.

      Type of study/level of evidence

      Therapeutic II.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Hand Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Badalamente M.A.
        • Hurst L.C.
        Enzyme injection as nonsurgical treatment of Dupuytren's disease.
        J Hand Surg. 2000; 25A: 629-636
        • Citron N.D.
        • Nunez V.
        Recurrence after surgery for Dupuytren's disease: a randomized trial of two skin incisions.
        J Hand Surg. 2005; 30B: 563-566
        • Becker G.W.
        • Davis T.R.
        The outcome of surgical treatments for primary Dupuytren's disease—a systematic review.
        J Hand Surg. 2010; 35B: 623-626
        • Rowley D.I.
        • Couch M.
        • Chesney R.B.
        • Norris S.H.
        Assessment of percutaneous fasciotomy in the management of Dupuytren's contracture.
        J Hand Surg. 1984; 9B: 163-164
        • Badois F.J.
        • Lermusiaux J.L.
        • Masse C.
        • Kuntz D.
        Non-surgical treatment of Dupuytren disease using needle fasciotomy [in French].
        Rev Rhum Ed Fr. 1993; 60: 808-813
        • Foucher G.
        • Medina J.
        • Malizos K.
        Percutaneous needle fasciotomy in dupuytren disease.
        Tech Hand Up Extrem Surg. 2001; 5: 161-164
        • Foucher G.
        • Medina J.
        • Navarro R.
        Percutaneous needle aponeurotomy: complications and results.
        J Hand Surg. 2003; 28B: 427-431
        • van Rijssen A.L.
        • Gerbrandy F.S.
        • Ter Linden H.
        • Klip H.
        • Werker P.M.
        A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study.
        J Hand Surg. 2006; 31A (717–715)
        • van Rijssen A.L.
        • Werker P.M.
        Percutaneous needle fasciotomy in Dupuytren's disease.
        J Hand Surg. 2006; 31B: 498-501
        • Cheng H.S.
        • Hung L.K.
        • Tse W.L.
        • Ho P.C.
        Needle aponeurotomy for Dupuytren's contracture.
        J Orthop Surg (Hong Kong). 2008; 16: 88-90
        • Rayan G.M.
        Nonoperative treatment of Dupuytren's disease.
        J Hand Surg. 2008; 33A: 1208-1210
        • Brandt K.E.
        An evidence-based approach to Dupuytren's contracture.
        Plast Reconstr Surg. 2010; 126: 2210-2215
        • Srinivasan R.C.
        • Shah A.S.
        • Jebson P.J.
        New treatment options for Dupuytren's surgery: collagenase and percutaneous aponeurotomy.
        J Hand Surg. 2010; 35A: 1362-1364
        • Norotte G.
        • Apoil A.
        • Travers V.
        A ten years follow-up of the results of surgery for Dupuytren's disease.
        Ann Chir Main. 1988; 7: 277-281
        • Foucher G.
        • Cornil C.
        • Lenoble E.
        Open palm technique for Dupuytren's.
        Ann Chir Main Memb Super. 1992; 11: 362-366
        • O'Gorman D.B.
        • Vi L.
        • Gan B.S.
        Molecular mechanisms and treatment strategies for Dupuytren's disease.
        Ther Clin Risk Manag. 2010; 6: 383-390
        • McFarlane R.M.
        • Jamieson W.G.
        Dupuytren's contracture.
        J Bone Joint Surg. 1966; 48A: 1095-1105
        • Smith A.C.
        Diagnosis and indications for surgical treatment.
        Hand Clin. 1991; 7: 635-642
        • Ketchum L.D.
        • Robinson D.W.
        • Masters F.W.
        Follow-up on treatment of hypertrophic scars and keloids with triamcinolone.
        Plast Reconstr Surg. 1971; 48: 256-259
        • Ketchum L.D.
        • Donahue T.K.
        The injection of nodules of Dupuytren's disease with triamcinolone acetonide.
        J Hand Surg. 2000; 25A: 1157-1162
        • Chowdri N.A.
        • Masarat M.
        • Mattoo A.
        • Darzi M.A.
        Keloids and hypertrophic scars: results with intraoperative and serial postoperative corticosteroid injection therapy.
        Aust N Z J Surg. 1999; 69: 655-659
        • Donaldson O.W.
        • Pearson D.
        • Reynolds R.
        • Bhatia R.K.
        The association between intraoperative correction of Dupuytren's disease and residual postoperative contracture.
        J Hand Surg. 2010; 35E: 220-223
        • Houck J.C.
        • Patel Y.M.
        Proposed mode of action of corticosteroids on the connective tissue.
        Nature. 1965; 206: 158-160
        • Ketchum L.D.
        Effects of triamcinolone on tendon healing and function.
        Plast Reconstr Surg. 1971; 47: 471-482
        • Meek R.M.
        • McLellan S.
        • Reilly J.
        • Crosson J.F.
        The effect of steroids on Dupuytren's disease: role of programmed cell death.
        J Hand Surg. 2002; 27B: 270-273
        • Pagnotta A.
        • Specchia N.
        • Soccetti A.
        • Manzotti S.
        • Greco F.
        Responsiveness of Dupuytren's disease fibroblasts to 5 alpha-dihydrotestosterone.
        J Hand Surg. 2003; 28A: 1029-1034
        • Meek R.M.
        • McLellan S.
        • Crossan J.F.
        Dupuytren's disease.
        J Bone Joint Surg. 1999; 81B: 732-738
        • Badalamente M.A.
        • Hurst L.C.
        Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture.
        J Hand Surg. 2007; 32A: 767-774
        • Hurst L.C.
        • Badalamente M.A.
        • Hentz V.R.
        • Hotchkiss R.N.
        • Kaplan F.T.
        • Meals R.A.
        • et al.
        Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
        N Engl J Med. 2009; 361: 968-979
        • Gilpin D.
        • Coleman S.
        • Hall S.
        • Houston A.
        • Karrasch J.
        • Jones N.
        Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.
        J Hand Surg. 2010; 35A: 2027-2038.e1
        • Desai S.S.
        • Hentz V.R.
        The treatment of Dupuytren disease.
        J Hand Surg. 2011; 36A: 936-942
        • Watt A.J.
        • Curtin C.M.
        • Hentz V.R.
        Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up.
        J Hand Surg. 2010; 35A: 534-539
        • Shih B.
        • Bayat A.
        Scientific understanding and clinical management of Dupuytren's disease.
        Nat Rev Rheumatol. 2010; 6: 715-726
        • Ebskov L.B.
        • Boeckstyns M.E.
        • Sorensen A.I.
        • Soe-Nielsen N.
        Results after surgery for severe Dupuytren's contracture: does a dynamic extension splint influence outcome?.
        Scand J Plast Reconstr Surg Hand Surg. 2000; 34: 155-160
        • Herweijer H.
        • Dijkstra P.U.
        • Nicolai J.P.
        • Van der Sluis C.K.
        Postoperative hand therapy in Dupuytren's disease.
        Disabil Rehabil. 2007; 29: 1736-1741

      Linked Article